Manns MP - Search Results

1

Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era.

Klose J, Klose MA, Metz C, Lehner F, Manns MP, Klempnauer J, Hoppe N, Schrem H, Kaltenborn A. Klose J, et al. Among authors: manns mp. Langenbecks Arch Surg. 2014 Dec;399(8):1021-9. doi: 10.1007/s00423-014-1214-6. Epub 2014 Jun 4. Langenbecks Arch Surg. 2014. PMID: 24888532 Free PMC article.

2

Hepatitis B virus mutations in the pre-S genome before and after liver transplantation.

Trautwein C, Schrem H, Tillmann HL, Kubicka S, Walker D, Böker KH, Maschek HJ, Pichlmayr R, Manns MP. Trautwein C, et al. Among authors: manns mp. Hepatology. 1996 Sep;24(3):482-8. doi: 10.1002/hep.510240303. Hepatology. 1996. PMID: 8781311

3

Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.

Lang H, Schlitt HJ, Schmidt H, Flemming P, Nashan B, Scheumann GF, Oldhafer KJ, Manns MP, Raab R. Lang H, et al. Among authors: manns mp. Langenbecks Arch Surg. 1999 Aug;384(4):370-7. doi: 10.1007/s004230050216. Langenbecks Arch Surg. 1999. PMID: 10473858 Review.

4

[Hepatitis and liver transplantation].

Klempnauer J, Manns MP. Klempnauer J, et al. Among authors: manns mp. Chirurg. 2000 Apr;71(4):404-9. doi: 10.1007/s001040050826. Chirurg. 2000. PMID: 10840608 Review. German.

5

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection.

Rosenau J, Bahr MJ, Tillmann HL, Trautwein C, Klempnauer J, Manns MP, Böker KHW. Rosenau J, et al. Among authors: manns mp. J Hepatol. 2001 Jun;34(6):895-902. doi: 10.1016/s0168-8278(01)00089-7. J Hepatol. 2001. PMID: 11451174

6

Immunosuppression and the prognosis of patients suffering from myeloproliferative disorders after liver transplantation.

Bahr MJ, Rosenau J, Tietge UJ, Caselitz M, Hofmann MW, Klempnauer J, Böker KH, Strassburg CP, Manns MP. Bahr MJ, et al. Among authors: manns mp. Transplant Proc. 2002 Aug;34(5):1493-4. doi: 10.1016/s0041-1345(02)02943-3. Transplant Proc. 2002. PMID: 12176453 No abstract available.

7

Risks and benefits of nucleosides before and after liver transplantation.

Tillmann HL, Klempnauer J, Manns MP. Tillmann HL, et al. Among authors: manns mp. Transplant Proc. 2003 Sep;35(6):2086-7. doi: 10.1016/s0041-1345(03)00674-2. Transplant Proc. 2003. PMID: 14529849 No abstract available.

8

Long-term outcome of liver transplantation for autoimmune hepatitis.

Vogel A, Heinrich E, Bahr MJ, Rifai K, Flemming P, Melter M, Klempnauer J, Nashan B, Manns MP, Strassburg CP. Vogel A, et al. Among authors: manns mp. Clin Transplant. 2004 Feb;18(1):62-9. doi: 10.1111/j.1399-0012.2004.00117.x. Clin Transplant. 2004. PMID: 15108772

9

[Liver transplantation: deciding between need and donor allocation].

Strassburg CP, Becker T, Klempnauer J, Manns MP. Strassburg CP, et al. Among authors: manns mp. Internist (Berl). 2004 Nov;45(11):1233-45. doi: 10.1007/s00108-004-1295-3. Internist (Berl). 2004. PMID: 15517126 German.

10

Retrospective analysis of the impact of immunosuppression on the course of recurrent hepatitis C after liver transplantation.

Bahr MJ, Beckermann JG, Rifai K, Gehrmann L, Rosenau J, Klempnauer J, Strassburg CP, Manns MP. Bahr MJ, et al. Among authors: manns mp. Transplant Proc. 2005 May;37(4):1703-4. doi: 10.1016/j.transproceed.2005.02.103. Transplant Proc. 2005. PMID: 15919437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,468 results

Search Page

Filters